Clinical Trial Update: Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia

View source ↗

Summary

The trial update evaluates whether persistence of human papillomavirus can be used to determine treatment efficacy in women with cervical dysplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia
• Human Papillomavirus Infection

Snippet

Sponsor: Lund University | Conditions: Human Papillomavirus Infection, Cervical Intraepithelial Neoplasia | Status: COMPLETED